BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
View Top Employees from BiomX IncWebsite | http://www.biomx.com |
Revenue | $22 million |
Funding | $56 million |
Employees | 104 (104 on RocketReach) |
Founded | 2015 |
Address | 7 Pinhas Sapir St Fl 2, Ness Ziona, Central District, IL |
Phone | +972 72-394-2377 |
Technologies |
JavaScript,
HTML,
PHP
+31 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Microbiome, Healthcare, Science and Engineering, Health Care, Drug Discovery, Drug Manufacturing & Research, Therapeutics, Phage Therapies |
Competitors | EnteroBiotix, Enterome, Leap Therapeutics, Rebiotix Inc (a Ferring Company), Visterra Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular BiomX Inc employee's phone or email?
The BiomX Inc annual revenue was $22 million in 2024.
Marina Wolfson is the CFO of BiomX Inc.
104 people are employed at BiomX Inc.
BiomX Inc is based in Ness Ziona, Central District.
The NAICS codes for BiomX Inc are [54171, 54, 541714, 541, 5417].
The SIC codes for BiomX Inc are [87, 873].